Abstract
Evidence of the existence of two forms of cyclooxygenases and the clinical relevance of COX-2 inhibition led to the development of COX-2 selective NSAIDs. In order to evaluate this selectivity, we have developed and validated an enzymatic method. The precision and reproducibility of the assay were determined and COX-2 selectivity examined using nimesulide and indometacin.
MeSH terms
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / pharmacology*
-
Indomethacin / pharmacology*
-
Isoenzymes / metabolism*
-
Prostaglandin-Endoperoxide Synthases / metabolism*
-
Substrate Specificity
-
Sulfonamides / pharmacology*
Substances
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoenzymes
-
Sulfonamides
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
nimesulide
-
Indomethacin